C-Reactive Protein Testing Market Size, Share & Industry Analysis, By Product (Reagent & Kits and Instruments), By Assay Type (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Immunoturbidimetric Assay, and Others), By Detection Range (Conventional CRP and hs-CRP), By Setting (Laboratory Testing and Point-of-Care (POC) Testing), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Regional Forecast, 2026-2034

Last Updated: January 12, 2026 | Format: PDF | Report ID: FBI107164

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Chronic Diseases, By Key Countries/Regions
2. Technological Advancements in C-Reactive Protein Testing
3. New Product Launches
4. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
5. Impact of COVID-19 on the Market
Global C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest of Asia Pacific
Latin America C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Abbott
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. Siemens Healthcare Private Limited
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. Quest Diagnostics Incorporated
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. Thermo Fisher Scientific, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. Merck KGaA
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. Getein Biotech, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. Randox Laboratories Ltd.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. BODITECH MED, INC.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  10. LumiraDx
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Chronic Diseases, By Key Countries/Regions
2. Technological Advancements in C-Reactive Protein Testing
3. New Product Launches
4. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
5. Impact of COVID-19 on the Market
Global C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest of Asia Pacific
Latin America C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Reagents & Kits
  2. Instruments
2. Market Analysis, Insights and Forecast – By Assay Type
  1. Chemiluminescence Immunoassay (CLIA)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Immunoturbidimetric Assay
  4. Others
3. Market Analysis, Insights and Forecast – By Detection Range
  1. Conventional CRP
  2. Hs-CRP
4. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
5. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Abbott
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. Siemens Healthcare Private Limited
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. Quest Diagnostics Incorporated
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. Thermo Fisher Scientific, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. Merck KGaA
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. Getein Biotech, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. Randox Laboratories Ltd.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. BODITECH MED, INC.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  10. LumiraDx
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global C-Reactive Protein Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global C-Reactive Protein Testing Market Value Share (%), by Product, 2025 & 2034

Figure 3: Global C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025 & 2034

Figure 4: Global C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025 & 2034

Figure 5: Global C-Reactive Protein Testing Market Value Share (%), by Setting, 2025 & 2034

Figure 6: Global C-Reactive Protein Testing Market Value Share (%), by End-User, 2025 & 2034

Figure 7: Global C-Reactive Protein Testing Market Value (USD billion), by Region, 2025 & 2034

Figure 8: North America C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034

Figure 9: North America C-Reactive Protein Testing Market Value Share (%), by Product, 2025

Figure 10: North America C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034

Figure 11: North America C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025

Figure 12: North America C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034

Figure 13: North America C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025

Figure 14: North America C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034

Figure 15: North America C-Reactive Protein Testing Market Value Share (%), by Setting, 2025

Figure 16: North America C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034

Figure 17: North America C-Reactive Protein Testing Market Value Share (%), by End-User, 2025

Figure 18: North America C-Reactive Protein Testing Market Value (USD billion), By Country, 2025 & 2034

Figure 19: North America C-Reactive Protein Testing Market Value Share (%), By Country, 2025

Figure 20: Europe C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034

Figure 21: Europe C-Reactive Protein Testing Market Value Share (%), by Product, 2025

Figure 22: Europe C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034

Figure 23: Europe C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025

Figure 24: Europe C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034

Figure 25: Europe C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025

Figure 26: Europe C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034

Figure 27: Europe C-Reactive Protein Testing Market Value Share (%), by Setting, 2025

Figure 28: Europe C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034

Figure 29: Europe C-Reactive Protein Testing Market Value Share (%), by End-User, 2025

Figure 30: Europe C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 31: Europe C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025

Figure 32: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034

Figure 33: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Product, 2025

Figure 34: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034

Figure 35: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025

Figure 36: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034

Figure 37: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025

Figure 38: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034

Figure 39: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Setting, 2025

Figure 40: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034

Figure 41: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by End-User, 2025

Figure 42: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 43: Asia Pacific C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025

Figure 44: Latin America C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034

Figure 45: Latin America C-Reactive Protein Testing Market Value Share (%), by Product, 2025

Figure 46: Latin America C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034

Figure 47: Latin America C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025

Figure 48: Latin America C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034

Figure 49: Latin America C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025

Figure 50: Latin America C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034

Figure 51: Latin America C-Reactive Protein Testing Market Value Share (%), by Setting, 2025

Figure 52: Latin America C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034

Figure 53: Latin America C-Reactive Protein Testing Market Value Share (%), by End-User, 2025

Figure 54: Latin America C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 55: Latin America C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025

Figure 56: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034

Figure 57: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Product, 2025

Figure 58: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034

Figure 59: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025

Figure 60: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034

Figure 61: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025

Figure 62: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034

Figure 63: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Setting, 2025

Figure 64: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034

Figure 65: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by End-User, 2025

Figure 66: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 67: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025

Figure 68: Global C-Reactive Protein Testing Market Share (%), By Company, 2025

List of Tables

Table 1: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 2: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021–2034

Table 3: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021–2034

Table 4: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 5: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021–2034

Table 6: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 7: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 8: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034

Table 9: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034

Table 10: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 11: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 12: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 13: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 14: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034

Table 15: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034

Table 16: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 17: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 18: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 19: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 20: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034

Table 21: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034

Table 22: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 23: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 24: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 25: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 26: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034

Table 27: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034

Table 28: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 29: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 30: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 31: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 32: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034

Table 33: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034

Table 34: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 35: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 36: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 180

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com